Argon laser trabeculoplasty: a review.

Area of Science:

• Ophthalmology
• Glaucoma Research
• Laser Therapy

Background:

• Open-angle glaucoma is a leading cause of irreversible blindness.
• Intraocular pressure (IOP) is a primary modifiable risk factor for glaucoma progression.
• Argon laser trabeculoplasty (ALT) is a common surgical intervention for glaucoma management.

Purpose of the Study:

• To review the efficacy and risks of argon laser trabeculoplasty (ALT) in treating open-angle glaucoma.
• To assess the long-term effectiveness and potential complications associated with ALT.
• To provide an overview of ALT as a therapeutic option in glaucoma management.

Main Methods:

• Review of existing literature on argon laser trabeculoplasty.
• Analysis of studies evaluating the pressure-lowering effects of ALT.
• Examination of reported complications and incidence rates associated with ALT.

Main Results:

• Argon laser trabeculoplasty (ALT) is effective in lowering intraocular pressure (IOP) for various open-angle glaucoma types.
• The pressure-lowering effect of ALT diminishes over time.
• Key risks include transient IOP elevation (20% incidence) and peripheral anterior synechia (20-46% incidence).

Conclusions:

• Argon laser trabeculoplasty (ALT) is a viable treatment for open-angle glaucoma, offering significant IOP reduction.
• The long-term effectiveness of ALT is limited by the diminishing pressure-lowering effect.
• Ongoing studies like the Glaucoma Laser Trial (GLT) are crucial for understanding the long-term impact of ALT.